Cargando…
Real-world results of definitive chemoradiation in carcinoma oesophagus: can SCOPE1 results be replicated outside trial setting?
BACKGROUND: Definite concurrent chemoradiation is the standard of care for locally advanced unresectable oesophageal cancers. However, heterogeneity exists in the practice of concurrent chemoradiation approaches. Here we describe the efficacy and toxicities of the standard arm of SCOPE1 protocol imp...
Autores principales: | Bhattacharyya, Tapesh, Harilal, Vishnu, Sashidharan, Rohit, Mallick, Indranil, Arunsingh, Moses, Chakraborty, Santam, Achari, Rimpa Basu, Chatterjee, Sanjoy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426028/ https://www.ncbi.nlm.nih.gov/pubmed/34567265 http://dx.doi.org/10.3332/ecancer.2021.1280 |
Ejemplares similares
-
Geographic disparities in access to cancer clinical trials in India
por: Chakraborty, Santam, et al.
Publicado: (2021) -
Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer Center
por: Basu Achari, Rimpa, et al.
Publicado: (2022) -
Can the CROSS protocol be safely implemented in real world scenario with broader eligibility criteria? Experience from a tertiary care centre in India
por: Bhattacharyya, Tapesh, et al.
Publicado: (2021) -
Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
por: Mallick, Indranil, et al.
Publicado: (2021) -
Immunohistochemistry Heterogeneity in Reported Breast Cancer Demographics From India: Triple-Negative Breast Cancer Rates Could Be Lower Than Suggested in Pooled Meta-Analysis
por: Chatterjee, Sanjoy, et al.
Publicado: (2016)